Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eran Matz

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Crohn'S & Colitis|February 26, 2024
The Epidemiology of Inflammatory Bowel Diseases During the COVID-19 Pandemic: Comparison of Two Nationwide CohortsOhad Atia, Nicklas Bryder, Adi Mendelovici, et al.
Rheumatology (Oxford, England)|May 30, 2024
Familial Mediterranean fever in patients with inflammatory bowel diseases: a nationwide study from the epi-IIRNMichal Kori, Rachel Buchuk, Ofra Goldzweig, et al.
Alimentary Pharmacology & Therapeutics|March 9, 2023
5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort studyOhad Atia, Idan Goren, Tali Sharar Fischler, et al.
World Journal of Methodology|January 17, 2024
Inflammatory bowel disease among first generation immigrants in Israel: A nationwide epi-Israeli Inflammatory Bowel Disease Research Nucleus studyMira Stulman, Gili Focht, Yiska Loewenberg Weisband, et al.
Inflammatory Bowel Diseases|January 8, 2024
Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN CohortOhad Atia, Chagit Friss, Gili Focht, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 15, 2021
Pediatric-onset Inflammatory Bowel Disease Has Only a Modest Effect on Final Growth: A Report From the epi-IIRNAmit Assa, Noa Assayag, Ran D Balicer, et al.
Plos One|September 5, 2023
Pediatric overweight and obesity increased in Israel during the COVID-19 periodAdam Rose, Eliana Ein Mor, Michal Krieger, et al.
Inflammatory Bowel Diseases|April 21, 2023
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRNOhad Atia, Ramit Magen Rimon, Natan Ledderman, et al.
Journal of Crohn'S & Colitis|August 23, 2024
Peripheral Blood Eosinophilia at Diagnosis of Inflammatory Bowel Disease Is Associated With Severe Disease Course: A Nationwide Study From the epi-IIRN CohortAnat Yerushalmy-Feler, Rona Lujan, Yiska Loewenberg Weisband, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2021
COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease ExacerbationRaffi Lev-Tzion, Gili Focht, Rona Lujan, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Crohn'S & Colitis|February 26, 2024
The Epidemiology of Inflammatory Bowel Diseases During the COVID-19 Pandemic: Comparison of Two Nationwide CohortsOhad Atia, Nicklas Bryder, Adi Mendelovici, et al.
Rheumatology (Oxford, England)|May 30, 2024
Familial Mediterranean fever in patients with inflammatory bowel diseases: a nationwide study from the epi-IIRNMichal Kori, Rachel Buchuk, Ofra Goldzweig, et al.
Alimentary Pharmacology & Therapeutics|March 9, 2023
5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort studyOhad Atia, Idan Goren, Tali Sharar Fischler, et al.
World Journal of Methodology|January 17, 2024
Inflammatory bowel disease among first generation immigrants in Israel: A nationwide epi-Israeli Inflammatory Bowel Disease Research Nucleus studyMira Stulman, Gili Focht, Yiska Loewenberg Weisband, et al.
Inflammatory Bowel Diseases|January 8, 2024
Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN CohortOhad Atia, Chagit Friss, Gili Focht, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 15, 2021
Pediatric-onset Inflammatory Bowel Disease Has Only a Modest Effect on Final Growth: A Report From the epi-IIRNAmit Assa, Noa Assayag, Ran D Balicer, et al.
Plos One|September 5, 2023
Pediatric overweight and obesity increased in Israel during the COVID-19 periodAdam Rose, Eliana Ein Mor, Michal Krieger, et al.
Inflammatory Bowel Diseases|April 21, 2023
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRNOhad Atia, Ramit Magen Rimon, Natan Ledderman, et al.
Journal of Crohn'S & Colitis|August 23, 2024
Peripheral Blood Eosinophilia at Diagnosis of Inflammatory Bowel Disease Is Associated With Severe Disease Course: A Nationwide Study From the epi-IIRN CohortAnat Yerushalmy-Feler, Rona Lujan, Yiska Loewenberg Weisband, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2021
COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease ExacerbationRaffi Lev-Tzion, Gili Focht, Rona Lujan, et al.
Pageof 4